News

Enhertu From AZ, Daiichi Sankyo Now Has The FDA Approval

With two significant FDA clearances in as many weeks, Enhertu from AstraZeneca and Daiichi Sankyo is blazing. On August 11th, the medication obtained rapid approval for use in people with non-small cell lung cancer (NSCLC) that has the HER2 mutation...

Pfizer Provides Evidence To Back The Clearance Of Prevnar 20

Although Pfizer beat Merck to sell its next-generation pneumococcal vaccination, it lost a more important battle in June when the FDA said its competitor may provide its next-generation shot to new-borns and young children. Two months later, Pfizer, playing catch-up,...

As A Rapid Response, ViiV Creates A $500,000 Monkeypox Fund

In a press statement, ViiV Healthcare stated that the Monkeypox Emergency Response Fund would be distributed to U.S. community-based organisations. ViiV, which has a strong relationship with the LGBTQ+ community and consistently ranks highly in pharma reputation rankings, stated in...

Hanmi Brings Back Liver Drug After Raising Its Efficacy

After leveraging its microemulsion technology to increase the absorption rate and so address a shortcoming of the original formulation, Hanmi Pharmaceutical has reintroduced its liver function medication. Hanmi from South Korea discovered silymarin, a derivative from the herb milk thistle,...

Almac Group Announces $65M Expansion of North American Headquarters in Pennsylvania

Almac Group, the global contract development and manufacturing organisation, today announces a $65 million, 100,000 ft2expansion of clinical supply operations at the company’s North American headquarters in Souderton, PA. The capital investment plan increases clinical capacity at the facility...

Sartorius to acquire Albumedix, strengthening its portfolio of innovative advanced therapy solutions

The life science group Sartorius, through its French listed subgroup Sartorius Stedim Biotech, has agreed to acquire 100 percent of Albumedix Ltd. from private investors. The Nottingham, UK-based company provides best-in-class recombinant albumin-based solutions. Recombinant human albumin is an...

3 Viruses The Pharmaceutical Industry Needs To Prepare For

More than half of the known infectious diseases are getting worse due to climate change. Monkeypox is expanding, and recently, news of an outbreak of the Langya henipavirus in China also leaked. Researchers and public health officials are looking...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read